文献速递肺结节与肺癌呼吸道感染

经支气管纵隔冷冻活检诊断纵隔病变:一项随机试验

Transbronchial mediastinal cryobiopsy in the diagnosis of mediastinal lesions: a randomised trial.
PubMed 文献 · Eur Respir J · 2021-12-09

这项随机试验纳入197例短轴≥1 cm的纵隔病变患者,在超声内镜引导下随机顺序行针吸活检和冷冻活检。冷冻活检总体诊断率91.8%,高于针吸活检的79.9%(p=0.001),在不常见肿瘤和良性疾病中优势明显,安全性可接受。

要点

  • 纵隔冷冻活检总体诊断率91.8%,显著高于针吸活检的79.9%。
  • 不常见肿瘤中冷冻活检敏感性91.7%,针吸活检仅25.0%。
  • 良性疾病中冷冻活检诊断率80.9%,针吸活检53.2%。

核心结论

  • 超声内镜引导下经支气管纵隔冷冻活检安全且有用,可提供纵隔病变的诊断性组织学样本。

研究设计与样本

  • 随机研究,纳入短轴≥1 cm的纵隔病变患者197例,线性EBUS识别病变后按随机顺序先后行针吸活检和冷冻活检。

主要发现

  • 总体诊断率针吸活检79.9%,冷冻活检91.8%(p=0.001)。
  • 转移性淋巴结诊断率针吸活检94.1%,冷冻活检95.6%(p=0.58)。
  • 不常见肿瘤敏感性针吸活检25.0%,冷冻活检91.7%(p=0.001)。
  • 良性疾病诊断率针吸活检53.2%,冷冻活检80.9%(p=0.004)。
  • 「TBNA先」与「冷冻活检先」两组诊断率无显著差异;观察到气胸2例、纵隔气肿1例。

临床怎么用

  • 对纵隔病变,尤其是疑诊不常见肿瘤或良性疾病时,可考虑在EBUS引导下行经支气管纵隔冷冻活检以提高诊断率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Guidelines recommend endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) as an initial investigatory technique for mediastinal nodal staging in lung cancer. However, EBUS-TBNA can be limited by the inadequacy of intact tissues, which might restrict its diagnostic yield in mediastinal lesions of certain aetiologies. We have previously shown that EBUS-guided transbronchial mediastinal cryobiopsy can provide intact samples with greater volume. METHODS: This randomised study determined the diagnostic yield and safety of transbronchial mediastinal cryobiopsy monitored by endosonography for the diagnosis of mediastinal lesions. Patients with a mediastinal lesion of ≥1 cm in the short axis were recruited. Following identification of the mediastinal lesion by linear EBUS, fine-needle aspiration and cryobiopsy were sequentially performed in a randomised order. Primary end-points were diagnostic yield, defined as the percentage of patients for whom mediastinal biopsy provided a definite diagnosis, and procedure-related adverse events. RESULTS: In total, 197 patients were enrolled and randomly allocated. The overall diagnostic yield was 79.9% and 91.8% for TBNA and transbronchial mediastinal cryobiopsy, respectively (p=0.001). Diagnostic yields were similar for metastatic lymphadenopathy (94.1% versus 95.6%, p=0.58), while cryobiopsy was more sensitive than TBNA in uncommon tumours (91.7% versus 25.0%, p=0.001) and benign disorders (80.9% versus 53.2%, p=0.004). No significant differences in diagnostic yield were detected between "TBNA first" and "Cryobiopsy first" groups. We observed two cases of pneumothorax and one case of pneumomediastinum. CONCLUSIONS: Transbronchial cryobiopsy performed under EBUS guidance is a safe and useful approach that offers diagnostic histological samples of mediastinal lesions.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Zhang J, Guo JR, Huang ZS, et al. Transbronchial mediastinal cryobiopsy in the diagnosis of mediastinal lesions: a randomised trial. Eur Respir J. 2021. PMID: 33958432. doi:10.1183/13993003.00055-2021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。